Daniel Lee Flynn, Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 508 shares at $48.87 ($25K) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Open-market sale of $25k DCPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-01-19 | $102K | — | Filing → |
| DCPH | SELL | 2022-06-21 | $19K | — | Filing → |
| DCPH | SELL | 2022-02-18 | $12K | — | Filing → |